Interstitial lung pathology: Should we test for autoantibodies to cellular antigens?

被引：0
作者：
Serelis, J. [1 ]
Athanasakos, A. [2 ]
Skopouli, F. N. [1 ]
Moutsopoulos, H. M. [3 ]
机构：
[1] Athens Euroclin, Dept Med & Clin Immunol, 7-9 Athanasiadou St, Athens 11521, Greece
[2] Univ Athens, Aiginite Hosp, Athens, Greece
[3] Acad Athens, Athens, Greece
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2019年 / 37卷 / 02期
关键词：
MYOSITIS; ANTIBODIES; MANAGEMENT; DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：340 / 341
页数：2
相关论文
共 11 条
  • [1] Barsotti S, 2017, CLIN EXP RHEUMATOL, V35, P875
  • [2] Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60 kDa antibodies: Results of a multicentric study
    Ghillani, P.
    Andre, C.
    Toly, C.
    Rouquette, A. M.
    Bengoufa, D.
    Nicaise, P.
    Goulvestre, C.
    Gleizes, A.
    Dragon-Durey, M. A.
    Alyanakian, M. A.
    Chretien, P.
    Chollet-Martin, S.
    Musset, L.
    Weill, B.
    Johanet, C.
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (09) : 509 - 513
  • [3] The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders
    Gofrit, S. G.
    Yonath, H.
    Lidar, M.
    Shoenfeld, Y.
    Kivity, S.
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (05) : 1257 - 1263
  • [4] Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy
    Hengstman, G. J. D.
    ter Laak, H. J.
    Egberts, Wt M. Vree
    Lundberg, I. E.
    Moutsopoulos, H. M.
    Vencovsky, J.
    Doria, A.
    Mosca, M.
    van Venrooij, W. J.
    van Engelen, B. G. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) : 1635 - 1638
  • [5] Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy
    Kao, AH
    Lacomis, D
    Lucas, M
    Fertig, N
    Oddis, CV
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (01): : 209 - 215
  • [6] Heterogeneity of autoantibodies in 100 patients with autoimmune myositis:: insights into clinical features and outcomes
    Koenig, Martial
    Fritzler, Marvin J.
    Targoff, Ira N.
    Troyanov, Yves
    Senecal, Jean-Luc
    [J]. ARTHRITIS RESEARCH & THERAPY, 2007, 9 (04)
  • [7] Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies
    Mecoli, Christopher A.
    Christopher-Stine, Lisa
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (05)
  • [8] Management of Myositis-Related Interstitial Lung Disease
    Morisset, Julie
    Johnson, Cheilonda
    Rich, Eric
    Collard, Harold R.
    Lee, Joyce S.
    [J]. CHEST, 2016, 150 (05) : 1118 - 1128
  • [9] A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies
    Pinal-Fernandez, Iago
    Casal-Dominguez, Maria
    Huapaya, Julio A.
    Albayda, Jemima
    Paik, Julie J.
    Johnson, Cheilonda
    Silhan, Leann
    Christopher-Stine, Lisa
    Mammen, Andrew L.
    Danoff, Sonye K.
    [J]. RHEUMATOLOGY, 2017, 56 (06) : 999 - 1007
  • [10] Anti-SRP auto-antibodies are not specific for myositis: Report of 8 cases
    Rodriguez-Muguruza, Samantha
    Lozano-Ramos, Ines
    Coll-Canti, Jaume
    Hernandez-Gallego, Alba
    Ojanguren, Isabel
    Martinez-Caceres, Eva
    Olive, Alejandro
    [J]. JOINT BONE SPINE, 2017, 84 (01) : 103 - 105
12